8C99C7EA.png
  • GV-971
    • Product overview
    • China Phase III Clinical Trial
    • Mechanism of Action
    • Clinical Guideline
    • Q&A
  • Scientific Research Information
    • GREEN MEMORY
    • Post-marketing Study
    • IIR Program
    • Relevant Literature
  • Information and Services
    • Master e-Classes
    • Typical Case
    • Case Study
    • Assessment Scale
    • Conference Information
    • News Reports
    • Pharmacovigilance
  • Company Website
CN
8C99C7EA.png
CN
  • GV-971
    • Product overview
    • China Phase III Clinical Trial
    • Mechanism of Action
    • Clinical Guideline
    • Q&A
  • Scientific Research Information
    • GREEN MEMORY
    • Post-marketing Study
    • IIR Program
    • Relevant Literature
  • Information and Services
    • Master e-Classes
    • Typical Case
    • Case Study
    • Assessment Scale
    • Conference Information
    • News Reports
    • Pharmacovigilance
  • Company Website
021-50540520
pvg-banner-81.png banph3-680.jpg

Information and Services

INFORMATION

  • Master e-Classes
  • Typical Case
  • Case Study
  • Assessment Scale
  • Conference Information
  • News Reports
  • Pharmacovigilance
Typical Case
Master e-Classes
Typical Case
Case Study
Assessment Scale
Conference Information
News Reports
Pharmacovigilance
Your location:
  • Home
  • Information and Services
  • Typical Case

Joined by thousands of doctors, the competition selects and shares a number of AD cases from across China to showcase how GV-971 facilitates patient treatment.

  • 2021-07-27
    Safeguard Memory to Ensure Healthy Aging
    Xu Luoyi
    Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine
  • 2021-07-27
    Sail against the Current – Thinkings about the Diagnosis and Treatment of an AD Patient
    Li Lin
    Tangdu Hospital of Air Force Medical University
  • 2021-07-27
    Why Do I Like “Bed-Wetting”?
     
    Hu Xiuxiu
    Nanjing Bed Hospital
  • 2021-07-27
    Unravel All Mysteries for Comprehensive and Standardized Treatment of AD Patients
    Tao Weiqun
    Shenzhen Kangning Hospital
  • 2021-07-27
    Still Alice – Sharing the Diagnosis and Treatment of an Early-Onset AD Patient
    Min Guowen
    First Hospital of Shanxi Medical University
  • 2021-07-27
    A "Simple" Case of Post-Stroke Cognitive Impairment
    Gong Li
    Tenth People's Hospital Affiliated to Tongji University
  • 2021-07-27
    Sodium Oligomannate Brings New Hope – Sharing the Treatment Process of AD Patients
    Wang Yu
    China-Japan Friendship Hospital
  • 2021-07-27
    Inter-Dependence – Sharing Sodium Oligomannate-Treated Cases
    Yuan Shiyun & Lv Yang
    First Affiliated Hospital of Chongqing Medical University
  • 2021-07-27
    Sharing the Diagnosis and Treatment of AD Cases
    Yuan Xiaoling
    Liaocheng People’s Hospital
  • 1
  • 2
Next
  • GV-971

    New hope for treating Alzheimer's disease worldwide

    img1.jpg
    webcode.png
  • Contact us

    Address: 421 Newton Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, China

    Phone: 021-50540520

  • Quick Links
    • Home
    • Contact Us
    • Scientific Research Information
    • Pharmacovigilance
    • News Reports
    • Company Website

Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

The information on this website is provided as knowledge only and shall not replace medical advice and medical consultation provided by physicians or other qualified healthcare professionals. The information on this website shall not be used for disease diagnosis.

©2022 GreenValley Inc.beian.png 沪公网安备31011502018352号沪ICP备2021021810号-3  Powered by Yongsy

Copyright Notice Legal Notices Terms of use